2022. Hydroxychloroquine Attenuates Myocardial Ischemic and Post-Ischemic Reperfusion Injury by Inhibiting the Toll-Like Receptor 9 – Type I Interferon Pathway. Cardiology and Cardiovascular Medicine. 6, 4 (Aug. 2022), 416–423.